Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-12-10Abscopal Effect from the Addition of Low-dose Radiotherapy in Metastatic Cancer Patients Receiving Stereotactic Body Radiotherapy: a Multicenter, Randomized Clinical Study
-
CLINICAL_TRIALS study record update · 2024-12-10Abscopal Effect from the Addition of Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiotherapy: a Multicenter, Single-arm Clinical Study (KROG 22-11)
-
CLINICAL_TRIALS study record update · 2024-12-09Circulating Tumor Cell (CTC) Quantification During Transurethral Resection (TURBT) and Plasma Kinetic Vaporisation (PKVBT) of Transitional Cell Carcinoma in Purging Fluid and Blood: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-12-09The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia Reality: a Qualitative Study and Framework Analysis
-
CLINICAL_TRIALS study record update · 2024-12-06Exercise for Fighting Oncology Repercussions After Treatment: the EFFORT Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-05Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older on Stable Antiretroviral Therapy Making a Switch to Bictegravir/Tenofovir Alafenamide/Emtricitabine
-
CLINICAL_TRIALS study record update · 2024-11-27Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome
-
CLINICAL_TRIALS study record update · 2024-11-22Endoscopic Detection of Early Neoplasia in Patients With Barrett's Esophagus
-
CLINICAL_TRIALS study record update · 2024-11-21A Study for Safety, Efficacy and Cellular Pharmacokinetics of CD7 CAR-T Cell for Patients With Relapsed or Refractory CD7 Positive T-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
-
CLINICAL_TRIALS study record update · 2024-11-21Clinical Study on Efficacy, Safety and Pharmacokinetics of CAR T Cell Injection in Patients With Recurrent or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-21Comprehensive and Deep Profiling in Cutaneous Squamous Cell Carcinomas to Unravel Treatment Efficacy in Immunotherapy Treated Patients
-
CLINICAL_TRIALS study record update · 2024-11-21Efficacy, Safety and Cytopharmacokinetics of RD13-02 Cell Injection in the Treatment of Patients With Recurrent or Refractory CD7-positive Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-21A Study to Evaluate 68Ga-N188 PET/CT Imaging of Nectin-4 Expression in Malignant Tumors
-
CLINICAL_TRIALS study record update · 2024-11-21A Phase Ib Study to Evaluate the Safety and Tolerability of MK-8353 in Combination With Pembrolizumab in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-19An Open-label Phase I Dose Finding Trial With BI 891065 Alone and in Combination With BI 754091 to Characterise Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Advanced and/or Metastatic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-19An Open Label, Dose-Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of TAK-981 in Adult Patients With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-15An Open-label, Multicenter Phase I Dose Escalation Study to Characterize Safety, Tolerability, Preliminary Anti-tumor Activity, Pharmacokinetics and Maximum Tolerated Dose of VIP152 (BAY 1251152) as Monotherapy or Combination Therapy in Subjects With Advanced Cancer.
-
CLINICAL_TRIALS study record update · 2024-11-15An Open-label, Multicenter Phase 1 Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity and Pharmacokinetics of VIP236 Monotherapy in Subjects With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2024-11-12Current Awareness, Perspective and Knowledge on Social Egg Freezing
-
CLINICAL_TRIALS study record update · 2024-11-07A Study to Evaluate 68Ga-P3 PET/CT Imaging of PSMA Expression in Prostate
-
CLINICAL_TRIALS study record update · 2024-11-07A Study to Evaluate 68Ga-P3 PET/CT Imaging of PSMA Expression in Malignant Tumors
-
CLINICAL_TRIALS study record update · 2024-11-07Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine
-
CLINICAL_TRIALS study record update · 2024-11-05The Expanded Access Use of Vorasidenib in Patients With IDH1 or IDH2 Mutated Glioma
-
CLINICAL_TRIALS study record update · 2024-10-29Biomolecular Effects of Topical Curcumin in HSIL Cervical Neoplasia
-
CLINICAL_TRIALS study record update · 2024-10-28Phase 1 Study to Identify the Immunomodulatory Activity of LY3022855 (IMC-CS4) in Patients With Advanced, Refractory Breast or Prostate Cancer